Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Societal Impact, History, Teaching, and Public Awareness

Why Is It so Hard to Do Good Science?

Ray Dingledine
eNeuro 4 September 2018, 5 (5) ENEURO.0188-18.2018; DOI: https://doi.org/10.1523/ENEURO.0188-18.2018
Ray Dingledine
1Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ray Dingledine
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1523/ENEURO.0188-18.2018
PubMed 
30197928
Published By 
Society for Neuroscience
History 
  • Received May 17, 2018
  • Revision received July 5, 2018
  • Accepted July 8, 2018
  • Published online September 4, 2018.
Copyright & Usage 
Copyright © 2018 Dingledine This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Author Information

  1. Ray Dingledine1
  1. 1Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322
  1. Correspondence should be addressed to Ray Dingledine, Ph.D., Department of Pharmacology, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, E-mail: rdingle{at}emory.edu.
View Full Text

Author contributions

  1. Author contributions: R.J.D. designed research; R.J.D. performed research; R.J.D. analyzed data; R.J.D. wrote the paper.

Disclosures

  • The author declares no competing financial interests.

  • This study was partially funded by the National Institute of Neurological Disorders and Stroke Grant R01NS097776.

Funding

  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)

    R01NS097776

Other Version

  • You are viewing the most recent version of this article.
  • previous version (September 04, 2018).

Online Impact

 

Article usage

Select a custom date range for the past year
E.g., 2023-03-26
to
E.g., 2023-03-26

Article usage: September 2018 to March 2023

AbstractFullPdf
Sep 2018280031391153
Oct 2018599712330
Nov 2018388667207
Dec 201829226074
Total 2018407947781764
Jan 201914334750
Feb 20191830728
Mar 20192427036
Apr 20192225119
May 20191919320
Jun 2019415320
Jul 20191428523
Aug 20191633616
Oct 20191632722
Nov 20191325818
Dec 2019617414
Total 20192952901266
Jan 2020712014
Feb 20201010419
Mar 202071238
May 202076413
Jun 2020115517
Jul 202097614
Aug 20202416
Sep 202059513
Oct 2020818725
Nov 2020211218
Dec 202089717
Total 2020761074164
Jan 2021210213
Feb 202115616
Mar 2021811520
Apr 2021128311
May 202187716
Jun 202117416
Jul 202158225
Aug 202178216
Sep 202199816
Oct 202166730
Nov 202128126
Dec 202101168
Total 2021611033213
Jan 202218614
Feb 202247813
Mar 202217914
Apr 20223528
May 202215919
Jun 20224745
Jul 20220573
Aug 202223811
Sep 2022010716
Oct 2022515218
Nov 202226622
Dec 20229705
Total 202232918148
Jan 20232587
Feb 20230483
Mar 20231374
Total 2023314314
Total4546108472569
Back to top

In this issue

eneuro: 5 (5)
eNeuro
Vol. 5, Issue 5
September/October 2018
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Why Is It so Hard to Do Good Science?
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Why Is It so Hard to Do Good Science?
Ray Dingledine
eNeuro 4 September 2018, 5 (5) ENEURO.0188-18.2018; DOI: 10.1523/ENEURO.0188-18.2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Why Is It so Hard to Do Good Science?
Ray Dingledine
eNeuro 4 September 2018, 5 (5) ENEURO.0188-18.2018; DOI: 10.1523/ENEURO.0188-18.2018
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Prologue
    • The Law of Small Numbers
    • Intuitive Pattern Seeking
    • Ignoring the Likelihood of a New Result
    • Conclusions and Recommendations
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • Bayesian
  • cognitive psychology
  • decision making
  • premortem
  • reproducibility
  • rigor

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Societal Impact

  • Questionable Research Practices, Low Statistical Power, and Other Obstacles to Replicability: Why Preclinical Neuroscience Research Would Benefit from Registered Reports
  • Blood Analysis of Laboratory Macaca mulatta Used for Neuroscience Research: Investigation of Long-Term and Cumulative Effects of Implants, Fluid Control, and Laboratory Procedures
  • Factors That Influence Career Choice among Different Populations of Neuroscience Trainees
Show more Societal Impact

History, Teaching, and Public Awareness

  • Research Data Management and Data Sharing for Reproducible Research—Results of a Community Survey of the German National Research Data Infrastructure Initiative Neuroscience
  • DrosoPHILA: A Partnership between Scientists and Teachers That Begins in the Lab and Continues into City Schools
  • Some Tips for Writing Science
Show more History, Teaching, and Public Awareness

Subjects

  • History, Teaching, and Public Awareness
  • Societal Impact

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.